MMC Health Care Limited
Indian Pharmaceutical Exporter · Antihistamines & Allergy Specialist · $1.6M Total Trade · DGFT Verified
MMC Health Care Limited is an Indian pharmaceutical exporter with a total trade value of $1.6M across 3 products in 2 therapeutic categories. Based on 60 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Chlorpheniramine ($950.0K), Glucosamine ($473.2K), Chondroitin ($131.0K).
MMC Health Care Limited — Export Portfolio & Destination Treemap
Who is MMC Health Care Limited? — Company Overview & Market Position
MMC Health Care Limited is an Indian pharmaceutical exporter established on February 28, 1996, in Chennai, Tamil Nadu. The company is registered under the Corporate Identification Number (CIN) U93090TN1996PLC034651. It operates as a public limited company, classified as a non-government entity. The authorized capital stands at ₹25 million, with a paid-up capital of ₹13.67 million. As of March 31, 2024, the company reported a total export value of $1.6 million USD, encompassing 60 shipments across three products in two therapeutic categories. The registered office is located at No.34-B, SIDCO Industrial Estate, Thirumazhisai, Chennai, Tamil Nadu, 600124, India.
What Does MMC Health Care Limited Export? — Product Portfolio Analysis
Top Products by Export Value
MMC Health Care Limited Therapeutic Categories — 2 Specializations
MMC Health Care Limited operates across 2 therapeutic categories, with Antihistamines & Allergy (61.1%), Nutritional Supplements (38.9%), representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.
Antihistamines & Allergy
1 products · 61.1% · $950.0K
Nutritional Supplements
2 products · 38.9% · $604.2K
Product Portfolio — Top 3 by Export Value
MMC Health Care Limited exports 3 pharmaceutical products across 2 therapeutic categories.
| # | Product | Category | Export Value | Shipments | Market Share | Rank |
|---|---|---|---|---|---|---|
| 1 | Chlorpheniramine | Antihistamines & Allergy | $950.0K | 19 | 2.1% | 2 |
| 2 | Glucosamine | Nutritional Supplements | $473.2K | 32 | 3.6% | 8 |
| 3 | Chondroitin | Nutritional Supplements | $131.0K | 9 | 2.6% | 9 |
MMC Health Care Limited exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $1.6M. The top category is Antihistamines & Allergy (61.1% of portfolio), followed by Nutritional Supplements (38.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.
Key Metrics
Top Categories
Top Export Routes
Related Analysis
Need Detailed Data?
Shipment-level records, pricing & buyer contacts for MMC Health Care Limited.
Request DemoMMC Health Care Limited — Corporate Profile & Information
Headquarters, ownership, manufacturing facilities, and key leadership
1Corporate Overview
MMC Health Care Limited is an Indian pharmaceutical exporter established on February 28, 1996, in Chennai, Tamil Nadu. The company is registered under the Corporate Identification Number (CIN) U93090TN1996PLC034651. It operates as a public limited company, classified as a non-government entity. The authorized capital stands at ₹25 million, with a paid-up capital of ₹13.67 million. As of March 31, 2024, the company reported a total export value of $1.6 million USD, encompassing 60 shipments across three products in two therapeutic categories. The registered office is located at No.34-B, SIDCO Industrial Estate, Thirumazhisai, Chennai, Tamil Nadu, 600124, India.
2Manufacturing Facilities
MMC Health Care Limited operates its manufacturing facility in Thirumazhisai, Chennai, Tamil Nadu. The plant specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding production capacities and specialized manufacturing capabilities are not publicly disclosed.
3Key Leadership
The leadership team at MMC Health Care Limited includes:
- Nageswararao Gupta Manepalli: Managing Director, appointed on September 20, 2018.
- Sureshbabu Makam: Director, serving since September 28, 2015.
- Raghva Tayaru Aswani Manepalli: Director, appointed on March 1, 2019.
- Padmaja Rani Manepalli: Director, serving since September 20, 2018.
- Someswara Rao Manepalli: Director, appointed on September 29, 2018.
These individuals collectively oversee the strategic direction and operations of the company.
Where Does MMC Health Care Limited Export? — Destination Intelligence
Regulated market presence, emerging market penetration, and geographic strategy
1Regulated Markets
MMC Health Care Limited's export activities are primarily focused on the production and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's export portfolio is concentrated in two therapeutic categories: Antihistamines & Allergy (61.1%) and Nutritional Supplements (38.9%). The top three exported products are:
- Chlorpheniramine: $950,000 USD, ranking #2 with a 2.1% market share.
- Glucosamine: $473,000 USD, ranking #8 with a 3.6% market share.
- Chondroitin: $131,000 USD, ranking #9 with a 2.6% market share.
These figures indicate a diversified product range within the company's export portfolio. However, specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available.
2Emerging Markets
MMC Health Care Limited's export data does not provide specific information regarding its presence in emerging markets such as Africa, Latin America, and Southeast Asia. The company's export portfolio is concentrated in two therapeutic categories: Antihistamines & Allergy (61.1%) and Nutritional Supplements (38.9%). The top three exported products are:
- Chlorpheniramine: $950,000 USD, ranking #2 with a 2.1% market share.
- Glucosamine: $473,000 USD, ranking #8 with a 3.6% market share.
- Chondroitin: $131,000 USD, ranking #9 with a 2.6% market share.
These figures indicate a diversified product range within the company's export portfolio. However, specific details regarding the company's presence in emerging markets and WHO prequalification enabling access are not publicly available.
3Geographic Strategy
MMC Health Care Limited's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the company's geographic diversification strategy, concentration risk, and strategic direction are not publicly available.
MMC Health Care Limited — Manufacturing & Regulatory Profile
FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record
1FDA Status
Specific details regarding MMC Health Care Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the company's FDA status are not publicly available.
2WHO & EU GMP
Specific details regarding MMC Health Care Limited's WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly available. The company's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the company's compliance with international quality standards are not publicly available.
3CDSCO & Indian Regulatory
Specific details regarding MMC Health Care Limited's Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, and export No Objection Certificates (NOCs) are not publicly available. The company's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the company's compliance with Indian regulatory requirements are not publicly available.
4Recent Regulatory Actions
Specific details regarding MMC Health Care Limited's Form 483 observations, warning letters, and import alerts are not publicly available. The company's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the company's recent regulatory actions are not publicly available.
MMC Health Care Limited — Competitive Positioning Among Indian Pharma Exporters
Market share comparison, key differentiators, and strategic analysis
1Competitive Landscape
Specific details regarding MMC Health Care Limited's top competitors in overlapping categories, market share comparison, and head-to-head analysis are not publicly available. The company's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the competitive landscape are not publicly available.
2Key Differentiators
Specific details regarding MMC Health Care Limited's unique strengths, competitive advantages, and product portfolio distinctions are not publicly available. The company's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the company's key differentiators are not publicly available.
3Strategic Position
Specific details regarding MMC Health Care Limited's current strategic direction, including focus on generics, specialty drugs, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services, and future outlook are not publicly available. The company's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the company's strategic position are not publicly available.
Buyer Due Diligence Brief — Evaluating MMC Health Care Limited as a Supplier
Track record assessment, certifications to verify, and pre-order checks
1Supplier Assessment
Specific details regarding MMC Health Care Limited's overall track record, export volume and consistency, and reliability indicators are not publicly available. The company's export data indicates a diversified product range within the company's export portfolio. However, specific details regarding the company's supplier assessment are not publicly available.
2Certifications to Verify
Importers should verify the following certifications when considering MMC Health Care Limited as a supplier:
- FDA Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.
- WHO-GMP Certification: Verify compliance with World Health Organization Good Manufacturing Practice standards.
- EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practice standards.
- ISO Certification: Check for relevant International Organization for Standardization certifications.
To verify each certification, contact the respective regulatory bodies or request copies of the certificates directly from MMC Health Care Limited.
3Due Diligence Checklist
When conducting due diligence on MMC Health Care Limited, consider the following steps:
- Verify Regulatory Compliance: Confirm the company's adherence to relevant regulatory standards, including FDA, WHO-GMP, EU GMP, and ISO certifications.
- Assess Financial Health: Review the company's financial statements for profitability, liquidity, and solvency indicators.
- Evaluate Manufacturing Capabilities: Assess the capacity, quality control measures, and technological capabilities of the manufacturing facility.
- Review Export Records: Examine the company's export history, including volume, consistency, and destinations.
- Check for Regulatory Actions: Investigate any past or ongoing regulatory actions, such as warning letters or import alerts.
Red flags to watch for include discrepancies in financial reporting, lack of transparency in regulatory compliance, and negative feedback from previous clients or regulatory bodies.
Recommended pre-order checks involve requesting copies of all relevant certifications, conducting site
Frequently Asked Questions — MMC Health Care Limited
How many pharmaceutical products does MMC Health Care Limited export from India?
MMC Health Care Limited exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Chlorpheniramine ($950.0K), Glucosamine ($473.2K), Chondroitin ($131.0K). Total export value is $1.6M.
What is MMC Health Care Limited's total pharmaceutical export value?
MMC Health Care Limited's total pharmaceutical export value is $1.6M, based on 60 verified shipments recorded in Indian Customs (DGFT) data.
What therapeutic categories does MMC Health Care Limited cover?
MMC Health Care Limited exports across 2 therapeutic categories. The largest are Antihistamines & Allergy (61.1%, 1 products), Nutritional Supplements (38.9%, 2 products).
Get Full MMC Health Care Limited Export Intelligence
Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Official References & Regulatory Resources
Verify manufacturer licensing, GMP certification, and export registration with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Matching: MMC Health Care Limited identified across shipments using name normalization.
- 2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 3.Market Share: Calculated per product as MMC Health Care Limited's capped value divided by total Indian exports for that product.
- 4.Shipment Count: Based on 60 individual customs records matching MMC Health Care Limited.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Products Tracked
2 therapeutic categories
Expert-Reviewed
By pharmaceutical trade specialists
Data Source & Methodology
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.